Laurion Capital Management LP - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 34 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$22,794
-18.1%
58,0000.0%0.00%
Q4 2022$27,840
-71.3%
58,0000.0%0.00%
-100.0%
Q3 2022$97,000
-41.2%
58,0000.0%0.00%
-66.7%
Q2 2022$165,000
-43.5%
58,0000.0%0.00%
-25.0%
Q1 2022$292,000
-49.5%
58,0000.0%0.00%
-33.3%
Q4 2021$578,000
-23.3%
58,0000.0%0.01%
+100.0%
Q3 2021$754,000
-10.7%
58,000
-3.3%
0.00%
-40.0%
Q2 2021$844,000
-14.4%
60,000
-3.2%
0.01%0.0%
Q1 2021$986,00062,0000.01%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders